WST
West Pharmaceutical Services, Inc. NYSE Listed Mar 17, 1980$322.01
Mkt Cap $22.7B
52w Low $202.79
98.7% of range
52w High $323.64
50d MA $261.86
200d MA $260.66
P/E (TTM)
44.0x
EV/EBITDA
27.0x
P/B
6.8x
Debt/Equity
0.1x
ROE
18.1%
P/FCF
42.4x
RSI (14)
—
ATR (14)
—
Beta
1.15
50d MA
$261.86
200d MA
$260.66
Avg Volume
976.5K
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
530 Herman O. West Drive · Exton, PA 19341-0645 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | AMC | 1.68 | 2.13 | +26.8% | 309.70 | +2.0% | -1.1% | -1.3% | -3.3% | +1.1% | +0.8% | — |
| Feb 12, 2026 | AMC | 1.83 | 2.04 | +11.5% | 243.61 | +0.1% | +2.8% | -2.9% | +2.1% | -1.8% | -1.1% | — |
| Oct 23, 2025 | AMC | 1.68 | 1.96 | +16.7% | 307.25 | +0.2% | -3.2% | -3.4% | -1.3% | +0.5% | -2.2% | — |
| Jul 24, 2025 | AMC | 1.51 | 1.84 | +21.9% | 279.10 | +0.0% | -5.6% | -2.2% | -1.9% | -1.5% | -4.0% | — |
| Apr 24, 2025 | AMC | 1.22 | 1.45 | +18.9% | 210.59 | +2.0% | +1.9% | +0.7% | -1.2% | -1.0% | -0.5% | — |
| Feb 13, 2025 | AMC | 1.71 | 1.82 | +6.4% | 199.11 | +1.8% | +7.8% | -1.7% | -4.0% | +0.6% | +3.6% | — |
| Oct 24, 2024 | AMC | 1.50 | 1.85 | +23.3% | 330.65 | -0.8% | -6.9% | +0.8% | +2.6% | -1.7% | -1.6% | — |
| Jul 25, 2024 | AMC | 1.74 | 1.52 | -12.6% | 277.16 | +0.9% | +2.7% | +1.2% | +4.0% | +2.2% | -1.3% | — |
| Apr 25, 2024 | AMC | 1.26 | 1.56 | +23.8% | 368.18 | -1.1% | -2.1% | -1.7% | +0.9% | +1.7% | +1.4% | — |
| Feb 15, 2024 | AMC | 1.78 | 1.83 | +2.8% | 350.70 | +0.0% | +3.2% | -3.3% | +1.7% | +1.0% | +2.1% | — |
| Oct 26, 2023 | AMC | 1.86 | 2.16 | +16.1% | 327.32 | -0.5% | -2.0% | -0.3% | -0.5% | +1.1% | +1.9% | — |
| Jul 27, 2023 | AMC | 1.93 | 2.11 | +9.3% | 354.90 | +1.1% | +3.0% | +0.7% | +1.0% | -0.3% | -0.2% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27 | Barclays | Maintains | Equal Weight → Equal Weight | — | $306.16 | $304.40 | -0.6% | -1.3% | -3.3% | +1.1% | +0.8% | +1.0% |
| Apr 14 | Barclays | Maintains | Equal Weight → Equal Weight | — | $259.96 | $261.18 | +0.5% | +3.1% | -0.5% | +1.2% | +1.5% | +1.6% |
| Feb 13 | Barclays | Maintains | Equal Weight → Equal Weight | — | $243.61 | $243.94 | +0.1% | +2.8% | -2.9% | +2.1% | -1.8% | -1.1% |
| Feb 3 | Evercore ISI | Maintains | Outperform → Outperform | — | $237.50 | $233.84 | -1.5% | -2.8% | +2.6% | -2.3% | +7.5% | -0.0% |
| Oct 27 | Barclays | Maintains | Equal Weight → Equal Weight | — | $297.47 | $299.99 | +0.8% | -3.4% | -1.3% | +0.5% | -2.2% | +1.3% |
| Oct 24 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $307.25 | $307.94 | +0.2% | -3.2% | -3.4% | -1.3% | +0.5% | -2.2% |
| Oct 24 | UBS | Maintains | Buy → Buy | — | $307.25 | $307.94 | +0.2% | -3.2% | -3.4% | -1.3% | +0.5% | -2.2% |
| Oct 23 | Evercore ISI | Maintains | Outperform → Outperform | — | $277.00 | $301.06 | +8.7% | +10.9% | -3.2% | -3.4% | -1.3% | +0.5% |
| Oct 2 | Barclays | Maintains | Equal Weight → Equal Weight | — | $271.42 | $269.52 | -0.7% | +0.6% | -0.2% | -1.6% | -0.8% | +0.7% |
| Jul 25 | Evercore ISI | Maintains | Outperform → Outperform | — | $279.10 | $279.10 | +0.0% | -5.6% | -2.2% | -1.9% | -1.5% | -4.0% |
| Jul 25 | Barclays | Maintains | Equal Weight → Equal Weight | — | $279.10 | $279.10 | +0.0% | -5.6% | -2.2% | -1.9% | -1.5% | -4.0% |
| Jul 25 | UBS | Maintains | Buy → Buy | — | $279.10 | $279.10 | +0.0% | -5.6% | -2.2% | -1.9% | -1.5% | -4.0% |
| Feb 14 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $199.11 | $202.67 | +1.8% | +7.8% | -1.7% | -4.0% | +0.6% | +3.6% |
| Dec 13 | BofA Securities | Maintains | Buy → Buy | — | $331.62 | $329.68 | -0.6% | -0.5% | +0.2% | +1.1% | -2.7% | +0.5% |
| Dec 12 | UBS | Upgrade | Neutral → Buy | — | $318.22 | $320.90 | +0.8% | +4.2% | -0.5% | +0.2% | +1.1% | -2.7% |
| Feb 16 | UBS | Maintains | Neutral → Neutral | — | $350.70 | $350.82 | +0.0% | +3.2% | -3.3% | +1.7% | +1.0% | +2.1% |
| Feb 13 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $406.63 | $402.43 | -1.0% | -2.0% | +2.4% | -14.1% | +3.2% | -3.3% |
| Feb 7 | Jefferies | Upgrade | Hold → Buy | — | $398.27 | $408.08 | +2.5% | +3.7% | -0.5% | -0.3% | -0.7% | -2.0% |
| Oct 27 | Stephens & Co. | Maintains | Overweight → Overweight | — | $327.32 | $325.73 | -0.5% | -2.0% | -0.3% | -0.5% | +1.1% | +1.9% |
| Aug 30 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $412.41 | $414.65 | +0.5% | -0.8% | -0.5% | +0.2% | -1.0% | +0.3% |
| Aug 21 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $387.77 | $389.90 | +0.5% | +1.3% | +0.1% | -0.0% | -0.3% | +0.5% |
| Jul 28 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $354.90 | $358.85 | +1.1% | +3.0% | +0.7% | +1.0% | -0.3% | -0.2% |
| Jul 17 | Stephens & Co. | Maintains | Overweight → Overweight | — | $385.13 | $385.19 | +0.0% | -0.4% | +0.3% | +0.3% | -1.8% | -0.4% |
| Jun 16 | BofA Securities | Upgrade | Neutral → Buy | — | $359.80 | $366.83 | +2.0% | +0.6% | +1.1% | +0.8% | -0.1% | -0.5% |
| Apr 11 | Stephens & Co. | Upgrade | Equal Weight → Overweight | — | $349.79 | $355.06 | +1.5% | +1.4% | +1.1% | +2.2% | -0.8% | -0.4% |
| Feb 17 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $319.77 | $317.18 | -0.8% | -1.9% | -2.2% | -0.4% | +2.1% | -0.6% |
| Dec 14 | Deutsche Bank | Maintains | Hold → Hold | — | $251.90 | $248.00 | -1.5% | -3.3% | -2.7% | -4.6% | +0.9% | -0.2% |
| Dec 2 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $242.02 | $235.58 | -2.7% | +1.0% | -2.0% | -1.9% | +0.4% | +0.1% |
| Nov 30 | UBS | Maintains | Neutral → Neutral | — | $223.50 | $224.11 | +0.3% | +5.0% | +3.1% | +1.0% | -2.0% | -1.9% |
| Oct 28 | BofA Securities | Downgrade | Buy → Neutral | — | $221.23 | $218.30 | -1.3% | +1.9% | +2.0% | -0.3% | -4.3% | -4.6% |
| Oct 28 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $221.23 | $218.30 | -1.3% | +1.9% | +2.0% | -0.3% | -4.3% | -4.6% |
| Jul 29 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $339.92 | $338.85 | -0.3% | +1.1% | -1.3% | +0.0% | +1.3% | -0.9% |
| Apr 29 | BofA Securities | Maintains | Buy → Buy | — | $325.36 | $323.07 | -0.7% | -3.2% | -0.9% | -1.9% | +3.9% | -1.2% |
| Apr 29 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $325.36 | $323.07 | -0.7% | -3.2% | -0.9% | -1.9% | +3.9% | -1.2% |
| Sep 15 | BofA Securities | Maintains | Buy → Buy | — | $452.06 | $453.73 | +0.4% | +0.1% | +0.4% | -1.3% | -0.9% | +0.8% |
| Jul 30 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $404.92 | $406.72 | +0.4% | +1.7% | +0.9% | +1.7% | +1.4% | -0.6% |
| Jul 30 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $404.92 | $406.72 | +0.4% | +1.7% | +0.9% | +1.7% | +1.4% | -0.6% |
| Apr 30 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $324.55 | $324.84 | +0.1% | +1.2% | +0.4% | -0.2% | -0.2% | +0.2% |
| Feb 19 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $296.74 | $297.68 | +0.3% | -5.1% | -3.2% | +0.6% | +1.7% | -0.4% |
| Nov 10 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $286.54 | $286.14 | -0.1% | -2.5% | +2.0% | +1.6% | +0.5% | +0.4% |
| Nov 10 | KeyBanc | Maintains | Overweight → Overweight | — | $286.54 | $286.14 | -0.1% | -2.5% | +2.0% | +1.6% | +0.5% | +0.4% |
| Oct 14 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $299.48 | $299.03 | -0.2% | -3.8% | +1.1% | +0.2% | -2.1% | +0.3% |
| Apr 24 | BofA Securities | Upgrade | Underperform → Neutral | — | $187.42 | $190.00 | +1.4% | +4.3% | +1.2% | -2.4% | -1.8% | -0.2% |
| Dec 12 | BofA Securities | Downgrade | Neutral → Underperform | — | $146.67 | $143.39 | -2.2% | -0.2% | -0.0% | +0.6% | +0.8% | +0.6% |
| Dec 12 | Bank of America | Downgrade | Neutral → Underperform | — | $146.67 | $143.39 | -2.2% | -0.2% | -0.0% | +0.6% | +0.8% | +0.6% |
| Jul 26 | BofA Securities | Upgrade | Underperform → Neutral | — | $132.86 | $134.30 | +1.1% | +3.0% | +1.1% | -0.6% | -0.2% | +0.0% |
| Jul 26 | Bank of America | Upgrade | Underperform → Neutral | — | $132.86 | $134.30 | +1.1% | +3.0% | +1.1% | -0.6% | -0.2% | +0.0% |
| May 1 | Jefferies | Downgrade | Buy → Hold | — | $123.79 | $121.45 | -1.9% | -2.6% | +1.0% | +0.8% | -0.1% | -1.1% |
| Apr 23 | William Blair | Maintains | Outperform → Outperform | — | $112.16 | $113.42 | +1.1% | +2.7% | +0.0% | +6.1% | +1.2% | -1.1% |
| Apr 25 | BofA Securities | Downgrade | Neutral → Underperform | — | $92.00 | $89.00 | -3.3% | -4.3% | +2.4% | -1.3% | -0.8% | -0.5% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | Winters ChadOff | VP, Chief Accounting Officer | Sell | 896 | $300.67 | $269K | 1,522 | +0.76% | +0.83% |
| Apr 27, 2026 | Favorite Annette FOff | Sr. VP & Chief HR Officer | Sell | 2,817 | $305.20 | $860K | 16,828 | +0.76% | +0.83% |
8-K · 7.01
! Medium
West Pharmaceutical Services, Inc. -- 8-K 7.01: Regulation FD Disclosure
West Pharmaceutical Services disclosed material information via Form 8-K on April 23, 2026, though the specific disclosure details are not provided in this filing excerpt.
Apr 23
8-K · 5.02
!!! Very High
West Pharmaceutical Services, Inc. -- 8-K 5.02: Executive Change
West Pharmaceutical Services' CEO and board chair announced plans to retire once a successor is identified, signaling a leadership transition that investors should monitor for potential operational continuity impacts.
Mar 9
8-K · 7.01
! Medium
West Pharmaceutical Services, Inc. -- 8-K 7.01: Regulation FD Disclosure
West Pharmaceutical Services disclosed CFO personnel information in a Regulation FD filing, which typically indicates routine executive updates rather than material business developments affecting investor returns.
Feb 12
Data updated apr 27, 2026 10:02am
· Source: massive.com